The in vivo host range of human T-cell leukemia virus type 1 (HTLV-1) has not been definitively established. To determine if hematopoietic stem cells from patients with adult T-cell leukemia-lymphoma (ATL) are infected with HTLV-1, we used a clonogenic progenitor assay followed by the polymerase chain reaction for the detection of HTLV-1 DNA. In vitro growth characteristics of myeloid (CFU-GM) and erythroid ( and a n arthropathy (HTLV-1 -associated arthropathy [HAAP]).'' Whereas ATL is a disease characterized by the clonal proliferation of HTLV-I-infected T cells, HAM/ TSP, HAB, and HAAP are generally considered to be caused by immunologic disorders secondary to HTLV-I infection. However, there is a paucity of information about the direct effects of HTLV-1 on target organs. HTLV-I has been shown to be T lymphotropic and to infect preferentially a CD4+ helper T-cell s u b~e t .~~-'~ However, in a n in vitro system, HTLV-1 can infect various cell types, including B-lymphocyte and myeloid cell^.^^-^' To obtain a better understanding of the natural history and pathogenesis of HTLV-1-associated diseases, it will be important to determine which cell types harbor the virus in infected patients. However, in vivo cellular tropism of HTLV-1 seems to be scarcely reported. Furthermore, it is not well established whether hematopoietic progenitor cells from patients with ATL are infected with HTLV-I.
H the causative agent of adult T-cell leukemia-lymphoma (ATL).I4 HTLV-1 has also been associated with a myelopathy (HTLV-1 -associated myelopathy/tropical spastic paraparesis [HAM/TSP]),5-8 a bronchopneumopathy (HTLV-I-associated bronchopneumopathy [HAB] ),9 and a n arthropathy (HTLV-1 -associated arthropathy [HAAP] ).'' Whereas ATL is a disease characterized by the clonal proliferation of HTLV-I-infected T cells, HAM/ TSP, HAB, and HAAP are generally considered to be caused by immunologic disorders secondary to HTLV-I infection. However, there is a paucity of information about the direct effects of HTLV-1 on target organs. HTLV-I has been shown to be T lymphotropic and to infect preferentially a CD4+ helper T-cell s u b~e t .~~-'~ However, in a n in vitro system, HTLV-1 can infect various cell types, including B-lymphocyte and myeloid cell^.^^-^' To obtain a better understanding of the natural history and pathogenesis of HTLV-1-associated diseases, it will be important to determine which cell types harbor the virus in infected patients. However, in vivo cellular tropism of HTLV-1 seems to be scarcely reported. Furthermore, it is not well established whether hematopoietic progenitor cells from patients with ATL are infected with HTLV-I.
In the present study, we investigated HTLV-1 infection in CD34' hematopoietic progenitor cells by using the polymerase chain reaction (PCR).
MATERIALS AND METHODS

Patients.
Ten patients who met the diagnostic criteria of ATL from the Lymphoma Study Group22 were enrolled in this study. Six healthy HTLV-I-seronegative volunteers were enrolled as controls. Written informed consent was obtained from all patients and controls. Clinical features of the 10 patients with ATL are shown in Table 1 .
Bone marrow specimens. Bone marrow (BM) was aspirated from the sternum into syringes containing preservative-free heparin. Light density BM mononuclear cells (BMMNCs) were isolated by Ficoll-Hypaque density-gradient centrifugation and adherent cells were depleted by incubating a cell suspension (2 X 106/mL) for 2 hours in a Petri dish. T cells were removed by using CD2-conjugated immunomagnetic beads (Dynabeads M-450 PanT; Dynal AS, Oslo, Norway). These nonadherent T-cell-depleted BMMNCs (NA-T-MNCs) were used for the following study.
Preparation of CD34+ cells for clonogenic progenitor assays. To examine the HTLV-1 DNA in individual colonies by PCR, we used CD34+ cells isolated by positive selection with the use of CD34-conjugated immunomagnetic beads (Dynabeads M-450 CD34; Dynal AS) to avoid picking non-colony forming cells. NA-T-MNCs suspended in Iscove's modified Dulbecco's medium (IMDM; GIBCO, Grand Island, NY) with 10% fetal calf serum (FCS; Intergen, Purchase, NY) were incubated with CD34-conjugated immunomagnetic beads for 1 hour at 4°C with gentle rotation, and CD34' cells were collected by using a magnet (MPC-1; Dynal AS). CD34-conjugated immunomagnetic beads were released by incubation with a goat anti-mouse-Fab polyclonal antibody (DETACHaBEADS; Dynal AS) at room temperature for 1 hour with gentle rotation. More than 90% of these isolated cells expressed CD34 when analyzed with flow cytometry (data not shown).
Preparation of CD34' cell for PCR analysis. NA-T-MNCs were labeled with a fluorescein isothiocyanate (F1TC)-conjugated anti-CD34 antibody (250 ng/ IO6) (HPCA-2; Becton Dickinson, Mountain View, CA). Cells were sorted on a fluorescence-activated cell sorter (FACS) (FACStar Plus; Becton Dickinson) equipped with a Consort 30 computer (Becton Dickinson). Cells were first selected for low vertical and wide horizontal light-scatter properties and then sorted for high-density expression of the CD34 antigen?3 These FACS-sorted CD34+ cells were used for PCR analysis without further preparation.
In vitro assays of hematopoietic progenitors. Clonogenic progenitor assays were performed according to the methylcellulose culture method with minor modifications as previously de~cribed.'~ Briefly, 1 X IOs NA-T-MNCs were cultured in triplicate in a 1-mL volume of IMDM supplemented with 30% FCS, 40 ng of recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF; G r i n Brewery Co Ltd, Tokyo, Japan), 2 U ofrecombinant human erythropoietin (rhEpo, Kirin), 5 X lo-' mol/L 2-mercaptoethanol (2ME), and 0.8% methylcellulose in 35-mm culture dishes (Nunc 171099, Nunc, Inc, Naperville, IL) at 37°C under a humidified atmosphere with 5% CO2 in air. After 14 days ofculture, granulocyte-macrophage colonies (CFU-GM), erythroid bursts (BFU-E), and mixed-cell colonies (CFU-Mix) were counted under an inverted microscope.
For PCR analysis of individual colonies, 500 CD34+ cells were cultured in a I-mL volume of IMDM supplemented with 30% FCS, 50 ng of recombinant human interleukin-3 (rhIL-3; Kinn), 40 ng of rhGM-CSF, 2 U of rhEpo, 5 X mol/L 2ME, and 0.8% methylcellulose in 35-mm culture dishes at 37°C under a humidified atmosphere with 5% CO2 in air. After 14 days of culture, individual colonies were removed from the dish using a finely drawn Pasteur pipette under an inverted microscope and then processed for PCR analysis.
PCR analysis. DNA was extracted by a method previously describedZS with minor modifications. Briefly, l X lo3 BMMNCs, l X IO3 NA-T-MNCs, 1 X IO3 CD34+ cells, and individual colonies were suspended in 100 pL of a solution containing 10 mmol/L Tns-HCI (pH 8.3), 50 mmol/L KCI, 1,5 mmol/L MgCI,, 0.001% (wt/vol) gelatin, and 100 pg/mL of proteinase K. Samples were digested with proteinase K for 2 hours at 60"C, heated to 99°C for IO minutes, and quick chilled on ice. After a 5-minute centrifugation at 10,000 rpm, a pair of 45-pL supernatants were divided into two 0.5-mL PCR microcentrifuge tubes. These supernatants were mixed with 50 pmol/L of each primer, 125 pmol/L each deoxynbonucleoside triphosphate (dNTP) and 2 U thermostable DNA polymerase (AmpliTaq DNA polymerase; Perkin Elmer-Cetus, Norwalk, CT). For amplification of HTLV-I sequences, pX-specific primers, HS 1 (5'-GAAACAGCCCTGCAGATACA-Y) and HS2 (5'-AAAGCTGGTAGAGGTACATG-Y), and pX-specific nested primers, SK43 (5'-GGAGACTGTGTACAAGGCGA-3') and SK44 (5'-AGGGATAAGGAACTGTAGAGC-3')26 were used in a reaction cycle consisting of denaturation at 93°C for 1 minute, annealing at 6 I "C for 1 minute, and extension at 73°C for 1 minute. The amplification was performed on a programmed temperature system (PC-700; Astec, Tokyo, Japan) for 40 cycles. Of PCR products with HSI and HS2, 4% was added as a template to the second PCR reaction using nested primers SK43 and SK44. PCR samples were then run on an ethidium bromide-stained 1.5% agarose gel. Amplification of the @-globin gene using primers KM29 (5'GGTTGGCCAATCTACTCCCAGG-3') and KM38 (5'-TGG-TCTCCTTAAACCTGTCTTG-3')*' was independently performed as a control for DNA content and quality. As shown in Fig I, 
RESULTS
In vitro assays of hematopoietic progenitors. The mean number of CFU-GM and BFU-E colonies were 34.9 f 7.6 and 39.0 f 12.5 per 1 X lo5 NA-T-MNCs from 10 patients with ATL. These numbers of colonies were not significantly different from those observed in six normal controls (32.1 k 9.5 for CFU-GM and 41.4 + 12.7 for BFU-E) (P = .20) (Table 2 ). In addition, colonies formed by NA-T-MNCs from patients with ATL were morphologically similar to those from normal controls.
HTLV-1 pX was detected by PCR in all unseparated 1 X lo3 BMMNC samples from I O patients with ATL. HTLV-1 pX was also detected in all 1 X lo3 NA-T-MNCs and 1 X lo3 CD34' cells positively isolated by immunomagnetic beads. We attempted to evaluate HTLV-1 DNA in more purified hematopoietic cell populations. Because all cells from each colony are derived from a single progenitor,2s a copy of HTLV-1 DNA should be present in all daughter cells if it was present in the progenitor cell. With our two-step PCR method with nested primers, we could detect HTLV-I DNA if IO or greater infected cells are present in a sample. An individual colony contained 20 or more cells. Thus, this nested PCR was sensitive enough to detect HTLV-1 DNA from an individual colony. We analyzed HTLV-I pX in several colonies derived from CFU-Mix (4 to 22 colonies/patient; 75 in total), CFU-GM (25 to 66 colonies/patient; 3 18 in total) and BFU-E (25 to 66 colonies/patient; 318 in total) from IO patients with ATL. HTLV-I pX was not detectable in any of the colonies studied (Table 3) . We also analyzed HTLV-1 pX in
For FACS-sorted CD34' cells from six patients with ATL. None of these samples had PCR products of HTLV-I pX ( Table  4 ). The PCR result of unique patient number (UPN) 2 is shown in Fig 2. The intensity of PCR products of HTLV-I pX decreased along with procedures of T-cell depletion and CD34 positive isolation by immunomagnetic beads while they still existed. In contrast. FACS-sorted CD34' cells had no PCR products of HTLV-I pX. Although the source of HTLV-I DNA in NA-T-MNCs and CD34' cells positively isolated by immunomagnetic beads is unknown in this study. it is indicated that CD34' cells do not have HTLV-I DNA.
DISCUSSION
In this study, we characterized hematopoietic progenitor cells from patients with ATL and studied the in vivo tropism of HTLV-I. In patients infected with another human lymphotropic retrovirus, human immunodeficiency virus (HIV). hematologic abnormalities, such as peripheral blood cytopenias and morphologic changes of BM cells are frequently observed." However, in patients with ATL, peripheral blood cytopenia is unusual. although neutrophiliam and eosinophilia3' are occasionally seen. Neutrophilia and eosinophilia are generally considered to be caused by cytokines produced by ATL cell^,^"^^' yet characterization of hematopoietic progenitor cells from patients with ATL has not been reported. In the present study. hematopoietic progenitors from patients with ATL had normal colony-forming capacity in response to rhGM-CSF and rhEpo. Our data support that hematologic abnormalities such as neutrophilia and eosinophilia observed in patients with ATL are not caused by the abnormalities of hematopoietic progenitor cells themselves but probably reflect abnormalities in environmental factors such as cytokines.
To our knowledge, cellular tropism of HTLV-I for hema- Abbreviations: UPN, unique patient number; CFU-GM, colony-forming unit granulocyte-macrophage; BFU-E. burst-forming unit erythroid; ATL, adult T-cell leukemia-lymphoma.
Numbers of CFU-GM and BFU-E colonies obtained by culturing of 1 x lo5 NA-T-MNCs from 10 patients with ATL and 6 normal controls. Cultures were performed in triplicate and data are described as mean 2 SD. Abbreviations: UPN, unique patient number; CFU-GM, colony-forming unit granulocyte-macrophage; BFU-E, burst-forming unit erythroid; CFUMix, colony-forming unit mixed cell; HTLV-1, human T-cell leukemia virus type 1; PCR, polymerase chain reaction.
Five hundred CD34+ cells were cultured by the methylcellulose method. After 14 days of culture, individual colonies were picked up from the dish and DNA was extracted. To detect HTLV-1 DNA, twostep PCR with HTLV-1 pX-specific primers was performed.
For Clinically. the prognosis of patients with ATL is poor because ATL cells frequently develop resistance to chemo- For personal use only. on October 23, 2017 . by guest www.bloodjournal.org From
